Idiopathic Pulmonary Fibrosis Treatment Market Report 2022, Generate New challenges and Opportunities with Top Company Profiles – Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Cipla | Medgadget

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by a progressive and irreversible decrease in lung function, in which the walls of the air sacs (called alveoli) become thickened and damaged. Common symptoms count fatigue, sticky nails shortness of breath, and dry cough. Some other symptoms are joint pain, muscle pain, and weight loss. Further complications count pneumonia, pulmonary embolism, heart failure, and high blood pressure.
read more..